Clinical Disease Activity Index (CDAI) for Rheumatoid Arthritis
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۲۸ • واحد: joints
حداقل ۰ — حداکثر ۲۸ • واحد: joints
حداقل ۰ — حداکثر ۱۰ • واحد: 0-10 scale
حداقل ۰ — حداکثر ۱۰ • واحد: 0-10 scale
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Remission0–2.8
- Low Disease Activity2.8–10
- Moderate Disease Activity10–22
- High Disease Activity22–76
The Clinical Disease Activity Index (CDAI) for Rheumatoid Arthritis calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include tender joint count. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Determines severity of rheumatoid arthritis using only clinical data, without laboratory tests
Clinical Indication
The Clinical Disease Activity Index (CDAI) for Rheumatoid Arthritis is indicated for bedside clinical practice to support Determines severity of rheumatoid arthritis using only clinical data, without laboratory tests. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.
Limitations & Contraindications
Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.
Clinical Pearls & Action Plan
Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology. Guideline pearl: Allows immediate treatment decisions without waiting for lab results.
CDAI = Tender Joint Count (0-28) + Swollen Joint Count (0-28) + Patient Global Activity (0-10) + Provider Global Activity (0-10)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| tender_joint_count | integer | Yes | Number of tender joints (28-joint count)(joints) |
| swollen_joint_count | integer | Yes | Number of swollen joints (28-joint count)(joints) |
| patient_global_activity | float | Yes | Patient global assessment of disease activity (0-10 scale)(0-10 scale) |
| provider_global_activity | float | Yes | Provider global assessment of disease activity (0-10 scale)(0-10 scale) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–2.8 | Remission | Disease in remission |
| 2.8–10 | Low Disease Activity | Low disease activity |
| 10–22 | Moderate Disease Activity | Moderate disease activity |
| 22–76 | High Disease Activity | High disease activity |
Evidence-Based References (EBM)
- Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7(4):R796-806.
- Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, van Riel PL, Tugwell P. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003;42(2):244-57.
- Aletaha D, Smolen JS. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23(5 Suppl 39):S100-8.
Related calculators
- Disease Activity Score-28 for Rheumatoid Arthritis with CRP (DAS28-CRP)
- Disease Activity Score-28 for Rheumatoid Arthritis with ESR (DAS28-ESR)
- Clinical Disease Activity Index (CDAI) for Rheumatoid Arthritis
- ACR/EULAR 2010 Rheumatoid Arthritis Classification Criteria
- ACR/EULAR Gout Classification Criteria